Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 60

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Application of Targeted Mass Spectrometry for the Quantification of Sirtuins in the Central Nervous System

Jayasena, T., Poljak, A., Braidy, N., Zhong, L., Rowlands, B., Muenchhoff, J., Grant, R., Smythe, G., Teo, C., Raftery, M., Sachdev, P. · 2016 · Scientific Reports

Abstract

Sirtuin proteins have a variety of intracellular targets, thereby regulating multiple biological pathways including neurodegeneration. However, relatively little is currently known about the role or expression of the 7 mammalian sirtuins in the central nervous system. Western blotting, PCR and ELISA are the main techniques currently used to measure sirtuin levels. To achieve sufficient sensitivity and selectivity in a multiplex-format, a targeted mass spectrometric assay was developed and validated for the quantification of all seven mammalian sirtuins (SIRT1-7). Quantification of all peptides was by multiple reaction monitoring (MRM) using three mass transitions per protein-specific peptide, two specific peptides for each sirtuin and a stable isotope labelled internal standard. The assay was applied to a variety of samples including cultured brain cells, mammalian brain tissue, CSF and plasma. All sirtuin peptides were detected in the human brain, with SIRT2 being the most abundant. Sirtuins were also detected in human CSF and plasma, and guinea pig and mouse tissues. In conclusion, we have successfully applied MRM mass spectrometry for the detection and quantification of sirtuin proteins in the central nervous system, paving the way for more quantitative and functional studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep35391

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 43

  1. Haigis, M. C. & Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5, 253–295 (2010). · DOI · Paper page
  2. Gueguen, C., Palmier, B., Plotkine, M., Marchand-Leroux, C. & Bessson, V. C. Neurological and histological consequences induced by in vivo cerebral oxidative stress: evidence for beneficial effects of SRT1720, a sirtuin 1 activator, and sirtuin 1-mediated neuroprotective effects of poly(ADP-ribose) polymerase inhibition. PLoS One 9, e87367 (2014). · DOI
  3. Alcendor, R. R. et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100, 1512–1521 (2007). · DOI · Paper page
  4. Wang, F., Nguyen, M., Qin, F. X. & Tong, Q. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6, 505–514 (2007). · DOI · Paper page
  5. Lattanzio, F. et al. Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice. Neuroscience 256, 360–369 (2014). · DOI
  6. Kumar, R. et al. Sirtuin1: a promising serum protein marker for early detection of Alzheimer’s disease. PLoS One 8, e61560 (2013). · DOI · Paper page
  7. Kumar, R. et al. Identification of serum sirtuins as novel noninvasive protein markers for frailty. Aging Cell 13, 975–980 (2014). · DOI
  8. Weir, H. J. et al. CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer’s disease. PLoS One 7, e48225 (2012). · DOI
  9. Hoppner, S., Schanzer, W. & Thevis, M. Mass spectrometric studies on the in vitro generated metabolites of SIRT1 activating drugs for doping control purposes. Journal of mass spectrometry: JMS 48, 830–843 (2013). · DOI
  10. Liebler, D. C. & Zimmerman, L. J. Targeted quantitation of proteins by mass spectrometry. Biochemistry 52, 3797–3806 (2013). · DOI · Paper page
  11. Doerr, A. Mass spectrometry-based targeted proteomics. Nature methods 10, 23 (2013). · DOI
  12. Ji, S., Doucette, J. R. & Nazarali, A. J. Sirt2 is a novel in vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation. Journal of molecular cell biology 3, 351–359 (2011). · DOI
  13. Oh, C. L. E., Lee, Y. S. & Shin, D. H. SIRT2 Protein Expression in Normal and Aged Rat Brain. J Korean Geriatr Soc 16, 27–33 (2012). · DOI
  14. Pandithage, R. et al. The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J Cell Biol 180, 915–929 (2008). · DOI · Paper page
  15. Pais, T. F. et al. The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 32, 2603–2616 (2013). · DOI · Paper page
  16. Outeiro, T. F. et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease. Science 317, 516–519 (2007). · DOI · Paper page
  17. Luthi-Carter, R. et al. SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci USA 107, 7927–7932 (2010). · DOI · Paper page
  18. Ren, Y. et al. Effect of breed on the expression of Sirtuins (Sirt1-7) and antioxidant capacity in porcine brain. Animal: an international journal of animal bioscience 7, 1994–1998 (2013). · DOI
  19. Maxwell, M. M. et al. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet 20, 3986–3996 (2011). · DOI · Paper page
  20. Jeong, H. et al. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nature medicine 18, 159–165 (2012). · DOI · Paper page
  21. Khan, R. S., Dine, K., Das Sarma, J. & Shindler, K. S. SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease. Acta neuropathologica communications 2, 3 (2014). · DOI
  22. Satoh, A. et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab 18, 416–430 (2013). · DOI · Paper page
  23. Lu, C. T. et al. The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma. Anticancer research 34, 7137–7143 (2014).
  24. Lee, N. et al. Comparative interactomes of SIRT6 and SIRT7: Implication of functional links to aging. Proteomics 14, 1610–1622 (2014). · DOI
  25. Iwahara, T., Bonasio, R., Narendra, V. & Reinberg, D. SIRT3 functions in the nucleus in the control of stress-related gene expression. Molecular and cellular biology 32, 5022–5034 (2012). · DOI · Paper page
  26. Nishida, Y. et al. SIRT5 Regulates both Cytosolic and Mitochondrial Protein Malonylation with Glycolysis as a Major Target. Mol Cell 59, 321–332 (2015). · DOI · Paper page
  27. Li, F. et al. NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance. Mol Cell 60, 661–675 (2015). · DOI · Paper page
  28. Braidy, N. et al. Differential expression of sirtuins in the aging rat brain. Frontiers in cellular neuroscience 9, 167 (2015). · DOI
  29. Luna, B. et al. Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain Tumors. Molecular neurobiology 52 (3), 1341–63 (2015). · DOI
  30. Gatlin, C. L., Kleemann, G. R., Hays, L. G., Link, A. J. & Yates, J. R. 3rd Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry. Anal Biochem 263, 93–101 (1998). · DOI · Paper page
  31. Hou, X. et al. Cellular responses during morphological transformation in Azospirillum brasilense and Its flcA knockout mutant. PLoS One 9, e114435 (2014). · DOI
  32. Coumans, J. V., Poljak, A., Raftery, M. J., Backhouse, D. & Pereg-Gerk, L. Analysis of cotton (Gossypium hirsutum) root proteomes during a compatible interaction with the black root rot fungus Thielaviopsis basicola. Proteomics 9, 335–349 (2009). · DOI
  33. Guillemin, G. J. et al. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem 78, 1–13 (2001). · DOI · Paper page
  34. Simpson, R. Proteins and Proteomics: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, 2002).
  35. Muenchhoff, J. et al. Plasma protein profiling of mild cognitive impairment and Alzheimer’s disease across two independent cohorts. J Alzheimers Dis 43, 1355–1373 (2015). · DOI
  36. Sheipouri, D. et al. Characterisation of the kynurenine pathway in skin-derived fibroblasts and keratinocytes. Journal of cellular biochemistry 116, 903–922 (2015). · DOI
  37. Wu, W. et al. Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer’s disease brain. PloS one 8, e59749 (2013). · DOI · Paper page
  38. Komlos, D. et al. Glutamate dehydrogenase 1 and SIRT4 regulate glial development. Glia 61, 394–408 (2013). · DOI
  39. Shih, J., Mason, A., Liu, L., Higashimori, H. & Donmez, G. Loss of SIRT4 decreases GLT-1-dependent glutamate uptake and increases sensitivity to kainic acid. J Neurochem (2014). · DOI
  40. Glorioso, C., Oh, S., Douillard, G. G. & Sibille, E. Brain molecular aging, promotion of neurological disease and modulation by sirtuin 5 longevity gene polymorphism. Neurobiol Dis 41, 279–290 (2011). · DOI
  41. Favero, G., Rezzani, R. & Rodella, L. F. Sirtuin 6 nuclear localization at cortical brain level of young diabetic mice: An immunohistochemical study. Acta histochemica (2013). · DOI
  42. Schwer, B. et al. Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. Proc Natl Acad Sci USA 107, 21790–21794 (2010). · DOI · Paper page
  43. Zhong, L. & Mostoslavsky, R. SIRT6: a master epigenetic gatekeeper of glucose metabolism. Transcription 1, 17–21 (2010). · DOI

Cited by

Metadata

Authors
Jayasena, T., Poljak, A., Braidy, N., Zhong, L., Rowlands, B., Muenchhoff, J., Grant, R., Smythe, G., Teo, C., Raftery, M., & Sachdev, P.
Venue
Scientific Reports
Published
2016-10-20
Volume
6
Issue
1
ISSN
2045-2322
Cited by
60
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.